Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 12:37PM ET
Dollar change
Percentage change
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsGlobal Return% 1Y1.02% Shs Outstand Perf Week4.00%
SponsorFidelity ETF Type Tagsequity Return% 3Y- Total Holdings65 Perf Month5.11%
Fund Family Bond Type Tagstechnology Return% 5Y- AUM53.89M Perf Quarter4.65%
Index- Average Maturity Tagsmedical Return% 10Y NAV% Perf Half Y4.63%
Index Weighting Commodity Type Tagsdisruptive Return% SI NAV/sh Perf Year-0.55%
Active/Passive Quant Type Tagsinnovation Flows% 1M0.00% 52W Range19.88 - 25.68 Perf YTD3.52%
Dividend TTM0.00 (0.00%) ESG Type Tags- Flows% 3M0.00% 52W High-2.38% Beta1.25
Dividend Ex-DateJun 21, 2024 Dividend Type Sector/Theme Flows% YTD0.00% 52W Low26.11% ATR (14)0.26
Expense0.50% Structure Type Region Flows% 1Y RSI (14)66.95 Volatility0.87% 0.81%
Option/ShortNo / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.43 Prev Close25.33
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume6.23K Price25.07
SMA204.12% SMA504.00% SMA2006.51% Trades Volume1,363 Change-1.05%
Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.